Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 09, 2024

BUY
$62.17 - $97.62 $342,308 - $537,495
5,506 New
5,506 $537 Million
Q1 2022

May 10, 2024

BUY
$122.89 - $171.74 $676,632 - $945,600
5,506 New
5,506 $761,000
Q1 2022

Mar 22, 2023

BUY
$122.89 - $171.74 $249,712 - $348,975
2,032 Added 58.49%
5,506 $761,000
Q1 2022

May 12, 2022

BUY
$122.89 - $171.74 $249,712 - $348,975
2,032 Added 58.49%
5,506 $761,000
Q4 2021

Jun 21, 2023

SELL
$156.0 - $265.78 $316,992 - $540,064
-2,032 Reduced 36.91%
3,474 $633,000
Q3 2021

Jun 21, 2023

SELL
$228.69 - $274.2 $464,698 - $557,174
-2,032 Reduced 36.91%
3,474 $898,000
Q2 2021

May 17, 2024

BUY
$169.89 - $231.37 $137,950 - $187,872
812 Added 30.5%
3,474 $798,000
Q2 2021

Jun 21, 2023

SELL
$169.89 - $231.37 $345,216 - $470,143
-2,032 Reduced 36.91%
3,474 $798,000
Q2 2021

Mar 22, 2023

BUY
$169.89 - $231.37 $137,950 - $187,872
812 Added 30.5%
3,474 $798,000
Q2 2021

Aug 16, 2021

BUY
$169.89 - $231.37 $137,950 - $187,872
812 Added 30.5%
3,474 $798,000
Q1 2021

May 17, 2024

BUY
$143.93 - $207.3 $383,141 - $551,832
2,662 New
2,662 $448,000
Q1 2021

Jun 26, 2023

SELL
$143.93 - $207.3 $409,336 - $589,561
-2,844 Reduced 51.65%
2,662 $448 Million
Q1 2021

Mar 22, 2023

SELL
$143.93 - $207.3 $88,516 - $127,489
-615 Reduced 18.77%
2,662 $448,000
Q1 2021

May 14, 2021

SELL
$143.93 - $207.3 $88,516 - $127,489
-615 Reduced 18.77%
2,662 $448,000
Q4 2020

Jun 22, 2023

SELL
$96.1 - $151.18 $214,206 - $336,980
-2,229 Reduced 40.48%
3,277 $477,000
Q3 2020

Jun 26, 2023

SELL
$90.16 - $107.61 $200,966 - $239,862
-2,229 Reduced 40.48%
3,277 $323,000
Q2 2020

May 24, 2024

BUY
$52.17 - $95.63 $170,961 - $313,379
3,277 New
3,277 $305 Million
Q2 2020

Jun 26, 2023

SELL
$52.17 - $95.63 $116,286 - $213,159
-2,229 Reduced 40.48%
3,277 $305,000
Q1 2020

Jul 12, 2023

SELL
$52.76 - $109.0 $117,602 - $242,961
-2,229 Reduced 40.48%
3,277 $181,000
Q4 2019

Jul 12, 2023

SELL
$69.39 - $97.59 $154,670 - $217,528
-2,229 Reduced 40.48%
3,277 $314,000
Q3 2019

Jul 12, 2023

SELL
$64.17 - $84.08 $143,034 - $187,414
-2,229 Reduced 40.48%
3,277 $232,000
Q2 2019

Jul 12, 2023

SELL
$70.1 - $85.17 $156,252 - $189,843
-2,229 Reduced 40.48%
3,277 $279,000
Q1 2019

Jul 13, 2023

SELL
$77.0 - $99.34 $171,633 - $221,428
-2,229 Reduced 40.48%
3,277 $278,000
Q4 2018

Jul 13, 2023

SELL
$83.85 - $110.34 $186,901 - $245,947
-2,229 Reduced 40.48%
3,277 $282,000
Q4 2018

Mar 22, 2023

SELL
$83.85 - $110.34 $137,010 - $180,295
-1,634 Reduced 33.27%
3,277 $282,000
Q4 2018

Feb 14, 2019

SELL
$83.85 - $110.34 $137,010 - $180,295
-1,634 Reduced 33.27%
3,277 $282,000
Q3 2018

Jul 13, 2023

SELL
$97.14 - $113.31 $216,525 - $252,567
-2,229 Reduced 40.48%
3,277 $371,000
Q3 2018

Mar 22, 2023

SELL
$97.14 - $113.31 $57,798 - $67,419
-595 Reduced 10.81%
4,911 $556,000
Q3 2018

Nov 14, 2018

BUY
$97.14 - $113.31 $158,726 - $185,148
1,634 Added 49.86%
4,911 $556,000
Q4 2017

Feb 15, 2018

BUY
$77.49 - $98.41 $253,934 - $322,489
3,277
3,277 $263,000

Others Institutions Holding HSKA

About HESKA CORP


  • Ticker HSKA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 10,818,900
  • Description
  • Heska Corporation sells veterinary and animal health diagnostic and specialty products for canine and feline healthcare markets in the United States, Canada, Mexico, Australia, France, Germany, Italy, Malaysia, Spain, and Switzerland. The company offers Element DC, Element DCX, Element DC5x veterinary chemistry analyzers for blood chemistry and ...
More about HSKA
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.